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  With ageing, there is a loss of adult stem cell function. However, there is no direct evidence 
that this has a causal role in ageing-related decline. We tested this using muscle-derived stem  /
  progenitor cells (MDSPCs) in a murine progeria model. Here we show that MDSPCs from old 
and progeroid mice are defective in proliferation and multilineage differentiation. Intraperitoneal 
administration of MDSPCs, isolated from young wild-type mice, to progeroid mice confer 
signiﬁ  cant lifespan and healthspan extension. The transplanted MDSPCs improve degenerative 
changes and vascularization in tissues where donor cells are not detected, suggesting that their 
therapeutic effect may be mediated by secreted factor(s). Indeed, young wild-type-MDSPCs 
rescue proliferation and differentiation defects of aged MDSPCs when co-cultured. These 
results establish that adult stem  /  progenitor cell dysfunction contributes to ageing-related 
degeneration and suggests a therapeutic potential of post-natal stem cells to extend health.                
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 A 
universal characteristic of ageing is the loss of regenerative 
capacity leading to an impaired ability to respond to stress 
and, therefore, increased morbidity and mortality  1 .  Th  is  has 
led to the hypothesis that ageing is caused, in part, by the loss of func-
tional adult stem cells necessary for tissue regeneration  2,3 .  Indeed, 
mice greater than two years of age have a signifi  cant reduction in the 
number and proliferative capacity of neural stem cells  4,5   and male 
germline stem cells  6,7  . In contrast, with ageing, haematopoietic 
stem cell (HSC) numbers are preserved but their function is lost  8,9 . 
Muscle satellite cells also lose stem cell properties with ageing, but 
their abundance in old age remains controversial  10 – 13 .  Ageing-
related changes in bone-marrow-derived mesenchymal stem cells 
(MSCs) include loss of proliferation and diff  erentiation potential, 
increase in senescence and loss of capacity to form bone   in vivo  14,15 . 
Similarly, MSCs derived from the bone marrow of patients with 
Hutchinson  –  Gilford progeria syndrome, a disease of dramatically 
accelerated ageing, are defective in their ability to diff  erentiate  16 . 
Adipose-derived multipotent cells show an age-dependent loss of 
self-renewal capacity and an increased propensity for adipogene-
sis  17  . Despite this extensive evidence for adult stem cell decline with 
ageing, it is not known whether old stem cells contribute to ageing-
related degenerative changes or are merely a biomarker of it. 
  Given that ageing-related degenerative changes are universal 
in the musculoskeletal system  18 – 20  , we investigated the impact of 
ageing on murine muscle-derived stem  /  progenitor cells (MDSPCs). 
MDSPCs are multipotent cells isolated from postnatal skeletal 
muscle through an established preplate technique  21,22 .  Th  ey have 
a capacity for long-term proliferation, are resistant to oxidative and 
infl   ammatory stress, show multilineage diff   erentiation and self-
renew, induce neovascularization, and stimulate regeneration of 
bone, skeletal and cardiac muscles  21,23 – 25 .  Th   ese cells likely reside 
in the perivascular niche  26 .  Th   ese characteristics raise the possibil-
ity that the loss of MDSPCs or related perivascular progenitor cells 
could contribute to sarcopenia, osteoporosis  27,28   and other degen-
erative diseases associated with ageing. 
  Here we examine MDSPC function in natural ageing and a 
mouse model of a human progeria. XFE progeroid syndrome is 
caused by mutations in   XPF   (xeroderma pigmentosum comple-
mentation group F) and characterized by dramatically accelerated 
ageing of the epidermal, haematopoietic, endocrine, hepatobiliary, 
renal, nervous, musculoskeletal and cardiovascular systems  29 .   XPF  
encodes one subunit of an endonuclease that together with its essen-
tial binding partner ERCC1 (excision repair cross complementation 
group 1) participates in numerous DNA repair mechanisms  30 .  XFE 
progeroid syndrome was modelled in the mouse by mutation of the 
  mErcc1   locus to titrate expression of ERCC1  –  XPF  31,32 .   Ercc1      −      /      −       
mice with undetectable levels of ERCC1  –  XPF have a severely 
reduced lifespan of 1 month (mth)  29,30,32   while   Ercc1      −      /   Δ    mice, 
expressing 10  %   of the normal level of ERCC1  –  XPF have a lifespan 
of 7      mths (refs     30, 32). Both strains faithfully mimic the systemic 
accelerated ageing of XFE progeroid syndrome and demonstrate a 
highly signifi  cant correlation with naturally aged mice at the level 
of histopathology, pathophysiology and genome-wide transcrip-
tional reprogramming  30,32,33,34  . Our results indicate that MDSPC 
function is adversely aff  ected with accelerated and natural ageing. 
Th   is dysfunction directly contributes to ageing-related degenerative 
changes since transplantation of functional MDSPCs was suffi   cient 
to extend healthspan and lifespan of progeroid mice. Furthermore, 
we provide evidence that the therapeutic eff  ect of MDSPCs may be 
mediated by secreted factors that act systemically.   
 Results  
  Loss of stemness properties with ageing   .    MDSPCs  are  slowly 
adhering cells isolated from skeletal muscle and enriched through 
a preplate technique  21,22  . Previously, we reported isolating these 
multipotent cells from young (3-week (wk)-old) mice  22,35 .  To 
determine whether MDSPCs could also be isolated from adult and 
old mice, we followed the same preplate technique, and the resulting 
cells were analysed for expression of stem  /  progenitor cell markers 
(CD34, Sca-1). Cells isolated from skeletal muscle of young (3-wks), 
adult (19-wks), and old wild-type (WT) (2-years (yrs)) mice through 
this technique expressed CD34 and Sca-1 (  Fig. 1a  ), establishing that 
MDSPCs could be isolated from mice of all ages. Although expression 
of CD34 appeared mildly attenuated in the older cell populations, 
Sca-1, which is a more stable marker of MDSPCs  36  , was similarly 
expressed in all three populations. Furthermore, MDSPCs isolated 
from adult WT mice showed multilineage diff  erentiation (  Fig. 1b  ). 
  To determine whether there is a loss of stem cell function with 
ageing and progeria, MDSPCs were isolated from old WT mice (2-
yrs) as well as progeroid  Ercc1      −      /      −       (2 – 3-wks) and  Ercc1      −      /   Δ   (5-mths) 
mice and their proliferation and diff  erentiation kinetics measured 
  in vitro  . As controls, MDSPCs were isolated from age-matched 
WT littermates of the progeroid mice and   Xpa      −      /      −        (xeroderma 
pigmentosum complementation group A) mice (3-wks), which are 
defective in nucleotide excision repair of DNA like ERCC1-defi  -
cient mice, but do not age rapidly  37  . To measure proliferation of 
MDSPCs, an equivalent number of cells from each population were 
plated, and live-cell imaging (LCI)  38   was used to measure growth 
kinetics ( Fig. 1c ). Analysis of images captured from the diff  erent cell 
populations revealed that proliferation of MDSPCs isolated from 
the old WT,   Ercc1      −      /      −        and   Ercc1      −      /   Δ    mice, but not   Xpa      −      /      −        mice, 
was signifi  cantly reduced relative to MDSPCs isolated from young 
WT mice (  *    P     <    0.05,  Tukey ’ s  test).  Th   e average population-doubling 
time (PDT) was prolonged in MDSPCs isolated from old mice 
[18     hours (h)] and progeroid mice (20  –  27     h) compared with young 
WT mice (15     h) (  Fig. 1c  ). In support of this, the division time (DT) 
of single cells tracked within the population, or analysed as iso-
lated clones, was also prolonged for old WT-MDSPCs and ERCC1-
defi  cient MDSPCs compared with young WT-MDSPCs (  Supple-
mentary Table S1  ). Th  ese data demonstrate that the proliferation 
capacity of MDSPCs diminishes with age. 
  To determine whether the capacity for myogenic diff  erentiation 
is aff  ected in old and progeroid MDSPCs, the cells were cultured 
to confl  uence and switched to diff  erentiation medium (low serum). 
Th   e young WT- and  Xpa      −      /      −       MDSPCs fused to form multinucleated 
myotubes expressing fast myosin heavy chain (f-MyHC), a marker 
of terminal myogenic diff  erentiation ( Fig. 1d ). In contrast, MDSPCs 
isolated from old WT and progeroid ERCC1-defi  cient mice formed 
signifi   cantly fewer and smaller myotubes indicating impaired 
diff   erentiation  ( Fig.  1d ;   *  P     <    0.001;  Kruskal – Wallis  ANOVA  on 
ranks). Th  e  diff  erentiation defect was confi  rmed by measuring the 
expression of myogenic diff  erentiation markers MyHC, desmin, and 
myogenin  ( Fig.  1e ).  Myogenic  diff  erentiation of individual MDSPC 
clones from old and progeroid mice was also signifi  cantly reduced, 
compared with young WT mice (  Supplementary Fig. S1  ;   *    P     <    0.001, 
Kruskal  –  Wallis ANOVA on ranks). Similarly, osteogenic and chon-
drogenic diff  erentiation of progeroid and old MDSPCs was attenu-
ated compared with cells isolated from young WT mice (  Fig. 1b  ). 
In contrast, the capacity for adipogenic diff  erentiation was retained 
in aged MDSPCs. To determine whether the myogenic diff  eren-
tiation defect translated   in vivo  , MDSPCs isolated from progeroid 
mice were injected intramuscularly (IM) into   mdx   mice, a model 
of Duchenne  ’  s muscular dystrophy  39  . Indeed, cells derived from 
  Ercc1      −      /   Δ    mice had an impaired ability to regenerate muscle fi  bres 
in dystrophic muscle compared with young WT-MDSPCs ( Fig. 1f,g ; 
  P     <    0.001,  Mann – Whitney  rank  sum  test).  Cumulatively,  these  data 
provide evidence of a signifi  cant loss of stemness properties, includ-
ing proliferation under clonogenic conditions, multipotential diff  er-
entiation and tissue regeneration, in MDSPC populations isolated 
from old and progeroid mice. 
  To rule out the possibility that the stem cell dysfunction was 
an artefact caused by extensive passaging of MDSPCs   ex vivo ,  we ARTICLE   
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measured the number of cells with stem  /  progenitor surface mark-
ers and capacity for myogenic diff  erentiation at the earliest possible 
time point following isolation from skeletal muscle. Preplate 1 and 
2 (pp1  –  2;   Fig. 2a  ), which constitute all cells directly isolated from 
skeletal muscle, were induced to diff  erentiate within 24     h of isola-
tion. f-MyHC positive myotube formation was impaired in cells 
isolated from the skeletal muscle of progeroid ERCC1-defi  cient 
mice compared with WT littermates (  Fig. 2b  ). Similarly, expression 
of a second terminal myogenic diff  erentiation marker, myogenin, 
was reduced in the ERCC1-defi   cient cells compared with WT 
controls (  Fig. 2c  ). Twenty-four-hours post-isolation from skeletal 
muscle, those cells that remained nonadherent were stained for 
surface markers Sca-1, CD34 and CD45 and analysed by fl  uorescence-
activated cell sorting (FACS) to quantify the mixed population 
of non-haematopoietic stem  /  progenitor cells in the muscle 
(  Fig. 2d  ). Sca-1 is expressed on adult stem cells, a sub-population of 
myoblasts  40  , muscle-derived fi   brogenic / adipogenic  progenitors 41 , 
and a non-myogenic population of cells that emerge in muscle with 
ageing  42 . 
 In  young  WT  mice,   ~ 20 %   of  the  cells  were  Sca-1     +       / CD34     +       /
 CD45     −       . In contrast,         <        10  %   of the cells isolated from old or pro-
geroid skeletal muscle were Sca-1      +       / CD34     +       / CD45     −      .  Averaging 
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           Figure  1     |          Measuring  MDSPC  proliferation,  differentiation,  and  regenerative  potential. (  a  ) rtPCR to measure stem  /  progenitor cell markers CD34 and 
Sca-1 in MDSPCs isolated from muscle of mice at various ages. Shown is a representative image from analysis of 3  –  4 independent MDSPC populations per 
genotype / age  at  passage  23 – 25.  ( b  ) rtPCR to measure differentiation markers. Peroxisome proliferator-activated receptor (PPAR) is an adipocyte marker; 
collagen 1 (Col-1) is an osteocyte marker; collagen-2 (Col-2) is a chondrocyte marker.   β  -Actin was the loading control. Shown is a representative image 
from analysis of three independent MDSPC populations of each genotype  /  age. (  c  ) Proliferation of MDSPCs measured by live-cell imaging. Plotted are 
the average number of cells at each time point calculated from 3  –  4 populations per genotype        ±    s.d.  ( *  P     <    0.05,  Tukey ’ s  test).  Average  PDT  was  calculated 
from analysis of 40 images per time point. (  d  ) Representative images of   in vitro   myogenic differentiation. Cells were immunostained for the terminal 
differentiation  marker,  f-MyHC  (red).  Scale  bar    =    100    μ m.  Quantiﬁ  cation of myogenic differentiation was calculated as the fraction of cells (DAPI, blue) 
expressing f-MyHC (red) from 3  –  4 cell populations per genotype        ±    s.d;   *  P     <    0.001  relative  to  young  WT-MDSPCs  (black  bar),  Kruskal – Wallis  ANOVA  on 
ranks. (  e  ) rtPCR to measure expression of the terminal differentiation markers, MyHC, desmin, and myogenin, after myogenic differentiation of MDSPCs 
isolated from mice of various genotypes  /  ages. Shown is a representative image from 3 MDSPC populations tested per group. (  f  ) Representative image 
of gastrocnemius muscle sections from dystrophic mice 14 days post-injection of WT or   Ercc1      −      /   Δ    MDSPCs to test myogenic differentiation   in vivo .  The 
sections were immunostained for dystrophin (red) to identify myoﬁ   bres  from  donor  cells.  Scale  bar    =    100    μ m.  ( g )  Quantiﬁ  cation of the donor myoﬁ  bre 
area in dystrophic mice transplanted with WT-MDSPCs (black bars) or MDSPCs from   Ercc1      −      /   Δ    mice (white bars). Plotted is the average number of 
myoﬁ  bres of each size range calculated from        >       2,000 ﬁ  bres analysed per   mdx  / SCID  mouse  ( n     =    8)  treated  with  2  independent  MDSPC  populations  per 
genotype. (  P     <    0.001,  for  all  distribution  ranges  except  101 – 150;  Mann – Whitney  rank  sum  test).  ARTICLE
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data from 3  –  5 populations of each genotype revealed a signifi  cant 
depletion of this population of cells as animal age (  Fig. 2e  ;   *    P     <    0.05; 
Tukey  ’  s test). Next, we plated an equivalent number of these sorted 
cells to directly compare the myogenic diff  erentiation  capacity 
between Sca-1      +       / CD34     +       / CD45     −        cells from the diff  erent genotypes 
and ages of mice. Myogenic diff  erentiation was signifi  cantly impaired 
in cells isolated from old or progeroid mice compared with young 
WT  mice  ( Fig.  2f,g ;   *  P     <    0.001;  Kruskal – Wallis  ANOVA  on  ranks). 
Th   ese data demonstrate that there is a loss of MDSPC cell number 
as well as capacity for myogenic diff  erentiation with ageing. 
  To determine whether there is a diff  erence in the function of 
muscle stem cells between aged and young organisms   in vivo ,  we 
examined muscle regeneration utilizing a well-established cardio-
toxin injury-induced model (  Supplementary Methods  )  43 .  Th  e 
total area of muscle regeneration, as defi  ned by centronucleated 
fi  bres, did not signifi  cantly diff  er between young WT, old WT, 
and progeroid mice (  Supplementary Table S2  ). However, there 
was a dramatic diff  erence in the average cross-sectional area of the 
regenerated myofi  bres in old and progeroid mice compared with 
young adult mice (  Fig. 3a  ). More than 50  %   of the centronucleated, 
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          Figure  2     |          Measuring  the  number  of  MDSPCs  isolated  from  murine  muscle  and  their  myogenic  potential. (  a  ) A schematic diagram showing the early 
passage cells analysed in this ﬁ  gure and the method used to isolate various populations of MDSPCs (pp1  –  pp6). (  b  ) Representative images of pp1  –  pp2 cells 
induced to undergo myogenic differentiation. Cells directly isolated from skeletal muscle of mice, using preplate technique (pp1 – pp2),  were  incubated  in 
fusion media to induce myogenic differentiation. Twenty-four hours post-isolation, adhering cells were trypsinized and plated at equal density and induced 
to undergo myogenic differentiation over 2  –  3 days. Cells from 2  –  3 independent populations of each genotype were immunostained for the terminal 
myogenic  differentiation  marker,  f-MyHC  (red).  Scale  bar    =    100    μ m.  ( c  ) rtPCR to measure the expression of the myogenic differentiation marker, myogenin 
in pp1  –  pp2 cells, induced to undergo myogenic differentiation. (  d )  Quantiﬁ  cation of Sca-1      +       / CD34     +       / CD45     −        cells in young WT-, old WT-, and progeroid- 
(  Ercc1      −      /      −      ,   Ercc1      −      /   Δ   ) murine skeletal muscle. Twenty-four hours after isolation from muscle, the cells that did not adhere in preplate 1 and 2 (that is, pp3) 
were analysed for stem  /  progenitor cell markers by FACS. The number in the upper right quadrants indicates the percent of Sca-1      +       / CD34     +       / CD45     −        cells 
isolated from 3  –  5 mice of each genotype  /  age. (  e  ) Graph indicating the average fraction of Sca-1      +       / CD34     +       / CD45     −        cells normalized to the weight of the 
cell pellet of pp3 cell populations. Error bars indicate        ±    s.d.   *  P     <    0.05,  Tukey ’ s  test,  relative  to  young  WT  cells.  ( f  ) Representative images of Sca-1      +       / CD34     +       /
 CD45     −        -sorted cells plated at equal density and induced to undergo myogenic differentiation. The cells were stained for the terminal myogenic marker, 
f-MyHC  (red).  Scale  bar    =    100    μ m.  ( g )  Quantiﬁ  cation of myogenic differentiation of Sca-1      +       / CD34     +       / CD45     −        cells isolated from the skeletal muscle of mice 
of various genotypes  /  ages measured as the percent of cells (DAPI, blue) expressing f-MyHC (red). Error bars indicate        ±       s.d. for cell populations isolated 
from 2  –  3 animals per genotype   *    P         <       0.001, Kruskal  –  Wallis ANOVA on ranks relative to young WT cells.    ARTICLE   
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dystrophin-positive myofi  bres in old and progeroid mice had an area 
of   ≤    500    μ m 2   ( Fig.  3b ).  In  contrast,      >    60 %   of  the  myofi  bres in young 
WT  mice  had  an  area  of      >    1,000    μ m 2  , indicative of signifi  cantly 
more mature regenerated myofi  bres  (  P     <    0.001;  Kruskal – Wallis 
ANOVA on ranks). In addition, Masson  ’  s Trichrome stain revealed 
increased fi  brosis in muscle of old and progeroid mice in compari-
son to young WT mice following injury ( Fig. 3c,d ;  *  P     <    0.05; Tukey ’ s 
test). Th   ese data demonstrate that muscle regeneration is delayed 
and impaired in aged organisms. Collectively, the data in   Figures 
2 and 3   support the conclusion that aged organisms have a muscle 
stem / progenitor  cell  defect.   
  Treating with young WT-MDSPCs extends life and healthspan   .  
  To determine whether the loss of functional MDSPCs contributes to 
ageing-related degenerative changes, we asked whether transplanta-
tion of young WT-MDSPCs aff  ects either the healthspan or lifespan 
of progeroid mice. Littermate pairs of   Ercc1      −      /      −        mice were injected 
intraperitoneally (IP) with 2  –  4  ×  10  5   young WT-, progeroid-, or 
old WT-MDSPCs per gram body weight or PBS at 17 days of age, 
and lifespan was measured (summarized in   Supplementary Table 
S3 ).   Ercc1      −      /      −        mice injected with young WT-MDSPCs showed 
pronounced weight gain and a signifi  cantly  extended  lifespan 
compared with sibling mutant animals injected with vehicle only 
( Fig.  4a ;   *  P     <    0.05,  Dunn ’ s  test).  In  an  identical  experiment,  early 
passage primary mouse embryonic fi   broblasts (MEFs) did not 
aff  ect the growth or lifespan of   Ercc1      −      /      −        mice (  Fig. 4a  ). Similarly, 
MDSPCs isolated from old WT or progeroid   Ercc1      −      /      −        mice did not 
have a signifi  cant impact on lifespan. 
 Th  e young WT-MDSPCs were also injected IP into   Ercc1      −      /   Δ   
mice at 6  –  7 wks of age and again 6      wks later. Th  e age at onset of 
characteristic progeroid symptoms was measured biweekly, includ-
ing dystonia, trembling, kyphosis, ataxia, muscle wasting, loss of 
vision, urinary incontinence and decreased spontaneous activity. 
Th  e results were compared with littermate   Ercc1      −      /   Δ    mice treated 
with vehicle only in a pairwise fashion. Th  e investigators were 
blinded to the treatment arm. Th  e ageing score, representing the 
fraction of symptoms that were delayed in mutant mice treated 
with MDSPCs compared with a mutant littermate treated with PBS, 
revealed a highly signifi  cant diff  erence between treatment groups 
( Fig. 4b ;  *  *  *  P     <    0.0008; Student ’ s  t -test). Th   ese data provide evidence 
that loss of stem cell function has a direct causal role in ageing-
related  degeneration.   
  Young WT-MDSPCs engraft   aft  er transplantation   .    To  address  the 
question of how MDSPCs could extend healthspan and lifespan, 
we asked whether the donor cells engraft  ed in host tissues. Young 
WT-MDSPCs, transduced with a retroviral vector containing   LacZ  
with a nuclear localization sequence (  nLacZ  ), were injected IP 
into   Ercc1      −      /      −        mice  ( n     =    8).  Fourteen  tissues  were  analysed  ( Sup-
plementary Table S4  ) for the presence of donor cells.   LacZ     +       c e l l s  
were detected in the parenchyma of the liver and kidney, as well as 
connective tissues associated with pancreas and spleen of all 
mice analysed (  Fig. 5  ). Similar results were obtained in animals 
euthanized from 1 to 9 wks post-injection.   LacZ     +      cells  were  also 
detected in lung, oesophagus, thymus, bladder  /  ureter, spinal cord, 
and bone marrow of at least one mouse (  Fig. 5  ;   Supplementary 
Fig. S2 ). Importantly, donor cells were not detected in the heart, brain, 
skeletal muscles, and lymph nodes of any mice. Th   e extent of donor 
cell engraft   ment and expansion is limited, indicating that the 
benefi  cial eff  ects of MDSPCs is not due to tissue reconstitution 
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     Figure  3     |          Measuring  muscle  regeneration  after  injury  in  old  and 
progeroid mice. To measure muscle stem  /  progenitor cell function   in vivo , 
cardiotoxin was injected directly into the gastrocnemius muscle of old WT 
(3-yr-old;   n     =    3),  adult  WT  (18 – 21-wk-old;   n     =    5),  and  progeroid   Ercc1      −      /   Δ   
(21-wk-old;   n     =    2  plus  8-wk-old;   n     =    3)  mice  to  induce  muscle  injury.  Two 
wks later, tissues were collected and stained for dystrophin (red) and nuclei 
(DAPI). (  a  ) Representative images of damaged muscle sections. Scale 
bar    =    100    μ m.  ( b )  Quantiﬁ  cation of the cross-sectional area of regenerating 
myoﬁ  bres after muscle injury of adult WT mice (black bars), progeroid 
  Ercc1      −      /   Δ    littermates (white bars) and old WT mice (grey bars). The area 
of      >    1,000  myoﬁ  bres was measured per group of mice. The distribution of 
ﬁ  bre size is indicated on the   x  -axis, representing increasingly more mature 
ﬁ  bres with increased size. The fraction of regenerating, centronucleated 
myoﬁ  bres of each size range is plotted. (  P     <    0.001,  Kruskal – Wallis  ANOVA 
on  ranks  at  0 – 250,  251 – 500,  and      >    1,000).  ( c  ) Trichrome staining of 
sections from the same damaged muscles to reveal areas of ﬁ  brosis (blue). 
Shown are representative images from 1 of 2  –  3 mice of each genotype 
analysed. (  d  ) Histogram indicating the area of ﬁ  brotic scarring following 
cardiotoxin injection. Plotted is the average fraction (  n     =    2 – 3  animals 
per genotype  /  age) of the area examined that is ﬁ  brotic in percent        ±    s.d. 
 *  P     <    0.05,  Tukey ’ s  test,  relative  to  young  WT.  Scale  bar    =    100    μ m.  ARTICLE
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by donor cells as is seen with haematopoietic stem cells in bone 
marrow  transplant.   
  Young WT-MDSPCs restore the function of aged MDSPCs   .     I n   a  
progeria model (  Ercc1      −      /      −        mice), young WT-MDSPCs had a thera-
peutic eff   ect.  However,  the  duration  of  the  experiment  (    <    3  wks) 
and the limited extent of engraft  ment of IP-injected MDSPCs, as 
far as we could detect, made it unlikely that this positive eff  ect was a 
result of substantial MDSPC engraft  ment, proliferation, diff  erentia-
tion and tissue regeneration. Th  us, we next asked whether young 
WT-MDSPCs confer their therapeutic eff  ects through a paracrine 
mechanism, requiring secreted factors. MDSPCs isolated from 
14-day-old progeroid   Ercc1      −      /      −        mice were co-cultured with the 
young WT-MDSPCs, using a transwell system (  Fig. 6a  ). Th  e  prolif-
eration of   Ercc1      −      /      −        MDSPCs was measured for 72     h while the cells 
were exposed to proliferation media from young WT-MDSPCs. 
Subsequently, the   Ercc1      −      /      −        MDSPCs were switched to low-serum 
media to measure myogenic diff  erentiation.  Th  e proliferation 
defect of   Ercc1      −      /      −        MDSPCs was signifi   cantly improved by co-
culture of the cells with young WT-MDSPCs (  Fig. 6b  ;   *    P     <    0.001, 
Mann  –  Whitney rank sum test). In addition, myogenic diff  eren-
tiation of   Ercc1      −      /      −        MDSPCs was improved aft  er co-culture with 
young WT-MDSPCs (  Fig. 6c  ). Likewise, impaired diff  erentiation of 
old WT-MDSPCs was rescued by conditioned media from young 
WT-MDSPCs. To quantify the improvement, MDSPCs from pro-
geroid   Ercc1      −      /      −        or old WT mice were grown in the presence of 
conditioned media from young WT-MDSPCs, then collected for 
immunodetection of the terminal myogenic diff  erentiation marker 
f-MyHC (  Fig. 6d  ). f-MyHC expression was dramatically increased 
(2.5  –  9  ×  ) if the cells were grown in the presence of media from 
young WT-MDSPCs compared with diff  erentiation media alone. 
Th   us young WT-MDSPCs were able to rescue, at least in part, the 
function (proliferation and diff   erentiation) of MDSPCs isolated 
from progeroid and old mice via secreted factors.     
  MDSPCs promote neovascularization and tissue regeneration   .  
    To determine whether secreted factors were indeed important for 
the therapeutic eff  ect of MDSPCs, we asked whether there was 
evidence of improved histopathology in tissues of treated ERCC1-
defi  cient mice in which transplanted MDSPCs were not detected, in 
particular, skeletal muscle and brain. We previously demonstrated 
that the regenerative potential of MDSPCs transplanted into skeletal 
muscle, heart and bone correlates with their ability to induce ang-
iogenesis  21,24,25,35,44 .  Th   us, we asked whether IP injection of young 
WT-MDSPCs had an eff  ect on the vasculature of the brain, as well 
as muscle fi  bre size. Muscle sections were stained for dystrophin to 
highlight muscle fi  bre perimeter and CD31 to identify endothelial 
cells within microvessels (  Fig. 7a  ). For each image, the total number 
of muscle fi   bres  and  CD31    +      cells  were  quantifi  ed, and the ratio 
( #   of  CD31    +      cells /  #   of  muscle  fi   bres) determined. Muscles of 
15-day-old   Ercc1      −      /      −        mice had signifi   cantly reduced numbers 
of  CD31    +      cells  at  the  periphery  of  muscle  fi  bres compared with 
WT  littermates  ( Fig.  7b ;  0.56  CD31    +      cells  per  fi  bre versus 1.25 for 
WT  mice;   *  P     <    0.001,  Student ’ s   t -test).  Th  e average muscle-fi  bre 
size was also signifi  cantly reduced in the   Ercc1      −      /      −        mice  (324    μ m 2 ) 
compared with WT littermates (  Fig. 7b  ; 734        μ m 2 ,   *  P     =    0.002, 
Mann  –  Whitney rank sum test). 
  IP injection of young WT-MDSPCs into   Ercc1      −      /      −        mice led to 
a signifi   cant  increase  in  the  number  of  CD31    +      cells  9   wks  post-
injection compared with untreated   Ercc1      −      /      −        mice that only live 
3 – 4  wks  ( Fig.  7b ;  1.05  CD31    +      vessels / fi  bre;     §   P     <    0.05,  Tukey ’ s 
test). Similarly, muscle-fi  bre size signifi  cantly increased (  Fig. 7b  ; 
1,580    μ m 2   cross-sectional area;    §   P     <    0.05,  Dunn ’ s  test).  It  is  impos-
sible to directly compare the fi  bre size between   Ercc1      −      /      −        mice 
transplanted with young WT-MDSPCs to untreated mutant 
animals of the same age because the latter don  ’  t live to 9 wks of age 
( Fig. 4a ). Nevertheless, muscle regeneration and growth was evident 
in   Ercc1      −      /      −        mice treated with MDSPCs. 
 Progeroid   Ercc1      −      /      −        mice show reduced vascularization in 
the brain compared with WT littermates at 3 wks of age ( Fig. 7c ;  Sup-
plementary Fig. S3  ). Although donor cells were not detected in the 
brain of   Ercc1      −      /      −        mice, cell transplantation signifi  cantly improved 
neovascularization in the brain of these progeroid mice. In 3-wk-
old   Ercc1      −      /      −        mice, the median area of cerebral cortex occupied by 
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       Figure  4     |          Measuring  the  impact  of  MDSPC  transplantation  on  the 
lifespan and healthspan of progeroid mice. (  a )  2 – 4 × 10 5   MDSPCs per 
gram body weight were injected into the peritoneal cavity of 17-day-old 
  Ercc1      −      /      −        mice and lifespan measured. The median lifespan of   Ercc1      −      /      −       
mice is 21 days; the maximum is 28 days  29  . The lifespan of   Ercc1      −      /      −        mice 
injected with two independent MDSPC populations isolated from young 
WT mice were compared with   Ercc1      −      /      −        mice injected with vehicle only 
(PBS), an equivalent number of WT MEFs, or MDSPCs isolated from old 
WT or progeroid   Ercc1      −      /      −        mice. Reported is the average lifespan from 4  –  10 
mice injected per treatment group. Error bars indicate s.e.m.   *    P     <    0.05, 
Dunn  ’  s test comparing the WT groups with all other treatment groups. 
A summary of the cell lines injected and number of animals transplanted 
can be found in   Supplementary Table S3  . (  b )  2 – 4   × 10 5   MDSPCs per gram 
body weight were injected into the peritoneal cavity of 7-wk-old   Ercc1      −      /   Δ   
mice and again at 13 wks of age. The age at onset of the characteristic, 
spontaneous, ageing-related symptoms seen in   Ercc1      −      /   Δ    mice was measured 
(MDSPC-treated mice, black diamonds) and compared with mice injected 
with vehicle only (PBS; grey squares). Reported is the average age at onset 
of each progeroid symptom in wks        ±     s.d.  ( n     =    8  mice  per  treatment  group). 
The ageing score is calculated as the fraction of symptoms that were delayed 
in a single   Ercc1      −      /   Δ    mice injected with young WT-MDSPCs compared with 
an age- and sex-matched mouse (usually a littermate) injected with PBS 
(  Supplementary Methods  ). The black bars denote the average ageing score 
for  each  group  ( *  *  *  P     <    0.0008,  Student ’ s   t -test).  ARTICLE   
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vasculature was 1.2  %  . In   Ercc1      −      /      −        mice injected with MDSPCs, 
vascularization increased approximately to the levels in 3-wk-old 
WT mice (2.2 versus 2.5  %  , respectively) and the improvement was 
sustained.   Ercc1      −      /      −        mice treated with MDSPCs that survived to 9 
wks of age, had a vascular area indistinguishable from age-matched 
WT mice (3.2 versus 3.1  %  ,   P     <    0.05,  Dunn ’ s  test).  Th   ese data dem-
onstrate that there is improvement in the histopathology of several 
tissues in which donor cell engraft  ment was not detected, suggest-
ing that MDSPCs exert their therapeutic eff  ect through secreted 
factors. 
  Using IM injection of   nLacZ  -labelled MDSPCs to localize 
donor-cell engraft   ment, we analysed host muscle for presence 
of   LacZ     +       m y o fi  bres and endothelial cells (  Fig. 8  ). Like IP, IM 
administration of young WT-MDSPCs into   Ercc1      −      /      −        mice (  Fig. 8a  , 
  n     =    3  mice  per  group)  led  to  a  signifi  cant increase in the number 
of  CD31    +      cells  ( Fig.  8b ;  1.06  CD31    +      vessels  per  fi  bre;    §   P     <    0.05, 
Tukey  ’  s test) compared with the non-injected   Ercc1      −      /      −        mice (0.56 
CD31    +      vessels / fi  bre). Th  e muscle-fi  bre cross-sectional area was 
also signifi  cantly increased (  Fig. 8b  ; 522 versus 324       μ m 2 ,    §   P     <    0.05, 
Dunn  ’  s test). At the site of injection, numerous myofi  bres with 
central or peripheral   LacZ     +      nuclei  were  identifi  ed, demonstrat-
ing that transplanted MDSPCs have the capacity to integrate into 
regenerated muscle fi  bres (  Fig. 8c  ). In addition, analysis of sections 
of the gastrocnemius distant from the injection site revealed a shift   
in the distribution of myofi  bre size towards larger regenerating 
fi  bres compared with contralateral non-injected muscle (  Fig. 8d  ; 
  P     <    0.001,  Mann – Whitney  rank  sum  test  at  151 – 300  and  301 – 450). 
Th   is suggests that IM injection of MDSPCs also aff  ected host myofi  -
bres through a paracrine mechanism, requiring secreted factors. 
Sections were also stained with X-gal and for CD31 to determine 
whether  donor  cells  co-localize  with  CD31    +      cells  ( Fig.  8e ).  Back-
ground staining in   Ercc1      −      /      −        mice was extensive, compared with 
  mdx    /  SCID mice, likely due to interstitial fi  brosis. In both cases, 
there was a lack of co-localization of   LacZ   and CD31 staining. 
Th  ese data are consistent with our previous fi  ndings  25,45   and the 
conclusion that transplanted MDSPCs do not directly contribute to 
blood vessels and thus likely drive host angiogenesis through 
secreted  factors.    
 Discussion 
  MDSPCs are stem  /  progenitor cells isolated from skeletal muscle, a 
tissue that universally declines in mass and function with ageing  20 . 
Th   is cell population cannot be discriminated from less multipotent 
progenitors strictly based on surface markers, and thus are diffi   cult 
to quantify. Nevertheless, MDSPCs were isolated from old WT mice 
and mice with accelerated ageing, using a well-established preplate 
technique  21,22  . In both cases, cell proliferation and multilineage dif-
ferentiation is signifi  cantly impaired relative to MDSPCs isolated 
from young WT mice (  Fig. 1  ). Furthermore, fewer cells expressing 
stem  /  progenitor cell markers are isolated from skeletal muscles of 
aged and progeroid mice (  Fig. 2  ). Finally, muscle from aged and 
progeroid mice has signifi   cantly reduced regenerative capacity 
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   Figure  5     |          Determination  of  the  site  for  donor  cell  engraftment  of  young  WT-MDSPCs.  2 – 4   × 10 5   young WT-MDSPCs expressing nuclear   LacZ   per gram 
body weight were injected IP into   Ercc1      −      /      −        mice to determine the sites of engraftment. Mice were injected at 12 days of age and euthanized 8  –  9 days later 
(  n         =       4) or injected at 17  –  19 days of age and tissues collected at the end of their lifespan (4  –  9-wks of age;   n     =    4).  Fourteen  organs / tissues  were  isolated, 
sectioned and stained with X-gal to identify donor cells (  Supplementary Table S4  ). (  a  ) Donor cells (  LacZ     +      stained  blue)  were  detected  in  the  pancreas, 
liver, spleen, and kidney of all host animals. Shown are representative images from four mice illustrating the site and extent of engraftment of donor cells. 
(  b  ) Donor cells were detected in the lung, esophagus, thymus and ureter of at least one mouse. Shown are images at multiple levels of magniﬁ  cation 
from tissue sections of one mouse per organ to illustrate the site and extent of engraftment. The level of magniﬁ  cation is indicated for each tissue 
section image.    ARTICLE
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following injury (  Fig. 3  ;   Supplementary Table S2  ), consistent 
with previous reports  11 .  Th  ese data establish that the function of 
MDSPCs is compromised with ageing, similar to neuronal, mesen-
chymal, haematopoietic, satellite, and adipose stem cells  4,15,17,46 – 48 . 
Th   e similarity of defi  cits in MDSPCs from old WT and progeroid 
mice extends the commonalities between accelerated ageing caused 
by a defect in DNA repair and natural ageing. Similar parallels were 
found between Hutchinson-Gilford progeria syndrome and ageing 
in the MSC compartment  49 . 
  Numerous studies provide evidence that the number and  /  or 
function of diverse adult stem cell populations decline with 
ageing  4,6,7,15,47,50,51  . However, these are largely correlative studies 
that do not discriminate whether changes in the stem cell compart-
ment have a causative role in ageing or are merely a consequence 
of ageing. Genetic studies revealed proteins and pathways essential 
for the maintenance of stem cell function. Mutation of these genes 
leads to foreshortened lifespan and early onset of some ageing-
related pathologies. For example, mice defi  cient in the polycomb 
protein BMI-1 have a short lifespan  52  , along with defects in self-
renewal of HSCs, leading to adult stem cell depletion  53 .  Similarly, 
mice defi  cient in HMGA2 show reduced stem cell numbers and 
function (self-renewal) throughout the central and peripheral nerv-
ous systems  54  . Finally, HSC function and regenerative capacity are 
signifi  cantly diminished in mice harbouring mutations in diverse 
DNA repair genes or telomerase (  Lig4  Y288C ,  Ku80      −      /      −      ,  Xpd  TTD , and 
  mTR      −      /      −       ) indicating that genome and telomere maintenance are 
crucial for stem cell function  55,56  . However, there is no evidence 
that loss of stem cell function is directly responsible for decreased 
lifespan and ageing-related pathology in these models. Here we 
demonstrate that transplantation of functional WT stem / progenitor 
cells isolated from juvenile mice into hosts harbouring dysfunc-
tional MDSPCs leads to a signifi  cant extension of healthspan and 
lifespan (  Fig. 4  ). Th   ese results provide experimental evidence that 
the loss of adult stem cell function directly contributes to ageing-
related phenotypes. 
  Interestingly, the function of MDSPCs from aged mice could be 
restored if they were co-cultured with young WT-MDSPCs (  Fig. 6  ). 
Similar results were seen   in vivo   using parabiosis  47 .  Th  ese obser-
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membrane inserts, at the same density, and in the same media. These co-cultures were placed in the LCI system for 72     h to acquire time-lapsed images 
to measure proliferation of the MDSPCs. As a control, each plate contained wells of   Ercc1      −      /      −        MDSPCs without transwell membrane inserts. 
(  b  ) Plotted is the average cell number at each time point calculated from the analysis of three independent populations of   Ercc1      −      /      −        MDSPCs co-cultured 
with young WT-MDSPCs (black line), or without (red line)        ±     s.d.   *  P     <    0.001,  Mann – Whitney  rank  sum  test.  ( c  ) The transwell inserts were removed after 
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tested by immunostaining the cells for f-MyHC (red). Shown are representative images. The nuclear counterstain is DAPI (blue). Scale  bar    =    100    μ m. 
(  d )  Quantiﬁ  cation of myogenic differentiation of old WT-MDSPCs after growth in media conditioned from young WT-MDSPCs. Young WT-MDSPCs were 
cultured for 2 days in proliferation media in collagen-coated ﬂ  asks, then treated with differentiation media for 3 days. The supernatant from these cultures 
was collected for use as conditioned media. MDSPCs from 21-day-old progeroid   Ercc1      −      /      −        mice and 2-yr-old WT mice were grown in the presence of this 
conditioned media or unconditioned differentiation media to determine the impact on myogenic differentiation as measured by immunoblot detection of 
f-MyHC. Densitometric quantiﬁ  cation of f-MyHC corrected for   β  -Actin is indicated below each lane.   ARTICLE   
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vations demonstrate that old, dysfunctional MDSPCs can be res-
cued by exogenous factors, rather than the cells being inherently 
defective. Th  is is in contrast to aged haematopoietic stem cells, 
which appear to have an intrinsic defect (reviewed in ref.     57). 
  IP administration of young WT-MDSPCs to progeroid mice 
promoted growth of the animals, decreased skeletal muscle 
atrophy, and stimulated neovascularization in the brain and 
muscle, despite the fact that donor cells were not detected in 
these tissues (  Figs 4 and 7  ). In addition, transplantation of young 
WT-MDSPCs directly into progeroid muscle led to muscle regen-
eration as well as host neovascularization, demonstrating a para-
crine mechanism requiring secreted factors (  Fig. 8  ). Th  ese  obser-
vations suggest that the mechanism by which MDSPCs promote 
healthspan and lifespan extension is likely through the secretion 
of stimulatory factor(s) that promote regeneration and that cells 
from old hosts lose this secretory phenotype. Th  is stimulatory 
factor may be necessary to overcome systemic  48   or  local 58   nega-
tive regulators of tissue regeneration in aged hosts. Identifi  cation 
of these secreted factors and methods to rejuvenate adult stem 
cells   ex vivo   will be critical for regenerative medicine. 
  Our data demonstrate that transplanted MDSPCs can have 
systemic eff  ects, leading to tissue regeneration in multiple organ 
systems. Th   erefore, MDSPCs may have therapeutic value for delay-
ing ageing-related functional decline and treating human progerias. 
It will be of critical importance to test other adult stem cell types for 
a similar therapeutic eff   ect.   
 Methods  
  Isolation of MDSPCs      .     All animal experiments were performed with the approval 
of the University of Pittsburgh Institutional Animal Care and Use Committee. 
Th   e fraction of slow-adhering cells referred to as MDSPCs were isolated from the 
skeletal muscle of mice via a modifi  ed preplate technique  21,22 .  Briefl  y, mouse skel-
etal muscle is enzymatically digested to a single-cell suspension and the cells are 
separated by their ability to adhere to collagen-coated fl  asks. Th   e cells that adhere 
2   h  post-plating  are  defi  ned as preplate 1 (pp1,   Fig. 2  ). Th   e non-adherent cells (pp2) 
are transferred to a fresh fl  ask aft   er  24   h.  Th   is is repeated fi  ve times to isolate the 
slowly adhering, stem-cell-enriched MDSPC population (pp6 labelled ft  ). MDSPCs 
were isolated from young WT (14  –  21-day-old; f1 C57BL  /  6:FVB  /  n or C57BL  /  10J), 
adult WT (19-wk-old; f1), old WT (2-yr-old; f1), progeroid   Ercc1      −      /      −        (14 – 21-day-
old; f1),   Ercc1      −      /   Δ    (19-wk-old; f1) and DNA-repair-defi  cient   Xpa      −      /      −        (21-day-old; 
C57BL  /  6) mice (  n     =    3 – 4  per  strain),  which  were  bred  at  the  University  of  Pittsburgh 
Division of Laboratory Animal Research. MDSPCs were cultured in proliferation 
medium  (PM):   DMEM  supplemented  with  10 %   horse  serum ,   10 %   fetal  bovine 
serum  (FBS) ,   1 %   penicillin – streptomycin   (all  from  Invitrogen),  and   0.5 %   chick 
embryo extract   (  Accurate Chemical  ), on collagen-type I-coated fl  asks. Primary 
MEFs used for transplantation were prepared from E13  –  15 day-old embryos and 
cultured  at  3 %   O 2   (ref.    32). 
  To isolate individual clones, 5  ×  10  5   MDSPCs were resuspended in 500       μ l  media 
and the   FACS Aria cytometer   (  Becton-Dickinson  ) was used to place one MDSPC 
per well in a 96-well collagen-I-coated plate containing 100       μ  l PM medium. Each 
well was manually checked to confi  rm the presence of a single cell. Cells were 
cultured  at  37    ° C,  5 %   CO 2  , in a humidifi  ed incubator and medium was changed 
every 2 days.     
  Proliferation  in vitro        .     Cells were plated at a density of 2,000     cells per well in a 
collagen-type-I – coated 12-well plate. An  imaging system  ( Automated Cell Technologies ) 
equipped with a   ×  20 objective was used to acquire images at 10-min intervals 
over a period of 72     h. Forty images at each time point were randomly selected and 
analysed from three independent experiments on three-to-four distinct cell lines. 
To estimate PDT, the experimental data sets for each population were curve-fi  t to 
the re-arranged Sherley model  38,59  , using nonlinear regression to determine the 
correlation coeffi   cient and dividing fraction for each cell genotype. 
 Th   e division time (DT) of individual cells within the population or of isolated 
clones was measured by determining the time between cytokinesis events using 
time-lapsed video recordings (72     h in duration). At least 30 cells were tracked over 
time in at least 3 MDSPC populations per genotype. For clonal experiments, cells 
were analysed within 5 days aft  er isolation of clones from pp6. Th  ree-to-four  clones 
were isolated from 2  –  3 MDSPC populations of each genotype. DT was, therefore, 
calculated from 6  –  12 clones per genotype (  Supplementary Table S1  ).     
  Differentiation   in vitro     .     To induce myogenic diff  erentiation, MDSPCs were plated 
at high confl  uence in PM for 2  –  3 days then shift  ed to diff  erentiation medium (DM: 
DMEM,  2 %   FBS,  1 %   penicillin – streptomycin).  Aft  er 2  –  3 days, immunostaining 
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        Figure  7     |          Host  muscle  ﬁ  bre size and tissue vascularization following 
intraperitoneal transplantation of young WT-MDSPCs. (  a ) 
Representative sections from the gastrocnemius muscle of 15-day-old 
WT and   Ercc1      −      /      −        mice, as well as   Ercc1      −      /      −        mice transplanted with 
young WT-MDSPCs at 17 days of age and allowed to live their full 
lifespan (  Ercc1      −      /      −        IP), immunostained for dystrophin (green), CD31 
(red), and DAPI (blue). Arrows indicate myoﬁ  bres lacking adjacent 
CD31    +      cells  (microvasculature).  Scale  bars    =    100    μ m.  ( b )  Quantiﬁ  cation 
of microvasculature and myoﬁ  bre size in these mice. Images from 4  –  8 
sections and 500  –  1,000 ﬁ  bres from 3 animals per group were analysed. 
Reported are the ratio of CD31    +        cells to dystrophin-positive muscle ﬁ  bres 
(left) and the average muscle ﬁ  bre size (cross-sectional area; right). Error 
bars indicate s.e.m.   *    P     <    0.001,  Student’s   t  -test comparing the   Ercc1      −      /      −       
mice with WT mice and    §   P     <    0.05,  Tukey ’ s  test  comparing  untreated 
and treated   Ercc1      −      /      −        mice; for myoﬁ  bre size   *    P     =    0.002,  Mann – Whitney 
rank sum test comparing the   Ercc1      −      /      −        mice with WT mice and    §   P     <    0.05, 
Dunn  ’  s Method comparing untreated and treated   Ercc1      −      /      −        mice. (  c ) 
Representative images from sections of the cerebral cortex of 21-day-
old WT and   Ercc1      −      /      −        mice, and   Ercc1      −      /      −        mice transplanted with young 
WT-MDSPCs. Tissue sections were stained for CD31 to detect the 
microvasculature. The percent of the tissue area representing vasculature 
was quantiﬁ  ed using bright ﬁ  eld images and Northern Eclipse software. 
Each circle plotted represents an individual mouse. The horizontal bar 
is the median (50th percentile) area. The box represents the 25th  –  75th 
percentile, and the error bars represent the 10th  –  90th percentile.   ARTICLE
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for f-MyHC, a marker of terminal myogenic diff  erentiation, was performed. Aft  er 
cold methanol fi  xation, cells were blocked with 5  %   goat serum and incubated 
with f-MyHC   mouse monoclonal antibody   (1:250;   Sigma-Aldrich  ),   secondary 
biotinylated IgG   (1:250;   Vector Laboratories  ) for 1     h, and   streptavidin-594   (1:500; 
  Sigma-Aldrich  ) for 15     min to fl  uorescently label the myotubes. To visualize the 
nuclei, the cultures were then incubated with   DAPI   (4  ′ ,  6 ′   diamidino-2-phyenylin-
dole,  100   ng   ml     −     1  ;   Sigma-Aldrich  ) for 10     min. For negative controls, the primary 
antibody was omitted or replaced with mouse or rabbit IgG. Fluorescent images 
were captured and processed using a   Leica     DMIRB microscope   equipped with a 
  QImaging     Retiga digital camera   both using   Northern Eclipse soft   ware   ( v.  6.0 ;   Empix 
Imaging ).  We  quantifi  ed the cells in at least 15 fi  elds each from 3 replica platings of 4 
independent experiments. Myogenic diff  erentiation was calculated as the percent of 
cells (the number of nuclei, detected by DAPI stain) expressing f-MyHC. 
  For adipogenic, osteogenic, and chondrogenic diff  erentiation, MDSPCs were 
seeded onto   6-well plates and lineage-specifi  c diff  erentiation media   (  Lonza  ) was 
added for 7 days. Expression of lineage-specifi  c markers was measured by reverse 
transcriptase PCR (rtPCR) as described in   Supplementary Methods and Supple-
mentary Table S5  .     
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         Figure  8     |          Measurement  of  host  muscle  ﬁ  bre size and tissue vascularization after intramuscular transplantation with young WT-MDSPCs. (  a )  The 
gastrocnemius muscle of 12-day-old   Ercc1      −      /      −        mice (  n         =       3 mice) was injected with young WT-MDSPCs. Tissues were isolated 5 days later (17 d) and 
sections were immunostained for dystrophin (green), CD31 (red), and DAPI (blue) and compared with untreated 15-day-old WT and   Ercc1      −      /      −        mice (from 
  Fig. 7  ). The white arrow denotes a centronucleated ﬁ   bre.  Scale  bar    =    100    μ m.  ( b )  Quantiﬁ  cation of microvasculature and myoﬁ  bre size in transplanted and 
untreated mice. Images from 4  –  8 sections from 3 animals per group were analysed. Reported is the ratio of CD31     +      cells to dystrophin-positive muscle 
ﬁ  bres (left),    §   P     <    0.05  between  untreated  and  treated   Ercc1      −      /      −        mice, Tukey  ’  s test. On the right is the average muscle ﬁ  bre size (cross-sectional area), 
   §   P     <    0.05  between  untreated  and  treated   Ercc1      −      /      −        mice, Dunn  ’  s test. Error bars indicate s.e.m. (  c  ) Seventeen day-old progeroid   Ercc1      −      /      −        mice (  n     =    10) 
were injected IM with WT-MDSPCs expressing nuclear   LacZ   to determine whether donor cells integrate into muscle ﬁ  bres and contribute to blood vessels. 
Five days later, the mice were euthanized and the gastrocnemius muscles were isolated for analysis. Muscle sections at the injection site were stained with 
X-gal, to detect donor cells, and eosin. Scale bar       =       50       μ m.  ( d  ) Histogram of the cross-sectional area distribution of myoﬁ  bres in the treated gastrocnemius 
muscles (black bars) compared the contralateral non-injected muscle (white bars). Data were collected from 6,000 ﬁ  bres from multiple sections of four 
mice per group. The distribution of ﬁ  bre size is indicated on the   x  -axis, representing increasingly more mature ﬁ  bres with increased size (  P     <    0.001,  Mann –
  Whitney rank sum test at 151  –  300 and 301  –  450). (  e  ) Sections from the injected muscles stained for CD31 to identify blood vessels (dark brown) and X-gal 
to identify donor cells (blue). Red arrowheads indicate CD31       +        capillary structures. Sections from dystrophic (  mdx    /  SCID) mice treated the same way are 
included as a positive control (right panels). Scale bars       =       50       μ m.    ARTICLE   
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  FACS   .     Th   e preplate technique was utilized to obtain cells from skeletal muscle  21 . 
Red blood cells were eliminated using a lysis buff  er before plating. Aft   er  24   h, 
nonadherent cells in pp3 were collected, centrifuged, resuspended in   mouse serum   
(1:10;   Sigma-Aldrich  ) on ice and counted. Cells were then labelled with rat mono-
clonal antibodies against CD34, Sca-1, and CD45 conjugated to   FITC, PE   (both 
from   BD Pharmingen  ), and   APC,   respectively (  Invitrogen  ). A separate fraction of 
each cell pellet was stained with equivalent volumes of isotype control antibod-
ies. Before analysis, 7-amino-actinomycin D (7-AAD) was added for exclusion of 
nonviable cells. Cells were analysed on a   FACSAria cytometer   using   FACS Diva 
soft  ware  , (  Becton Dickinson  ). Sorted gates were defi  ned based on separate cell 
portions that were labelled with equivalent amounts of appropriately conjugated 
isotype-matched control antibodies. Positive and negative gates were set by analys-
ing isotype or unstained control samples in each analysis. Th   e average percent of 
Sca-1      +       / CD34     +       / CD45     −        cells was normalized to pellet weight. To compare diff  eren-
tiation potential, an equal number of sorted cells from each group were plated in 
48-well plates and diff  erentiation was induced as described above.     
  Co-culture experiments   .      Ercc1      −      /      −        MDSPCs were plated in the lower compart-
ment of   Transwell Permeable Supports   (  Costar  ) in PM media at a density of 
3,000     cells per well. WT-MDSPCs were seeded into 6.5     mm transwell membrane 
inserts at the same density in PM media and placed above the ERCC1-defi  cient 
MDSPCs. Th   e 24-well plates containing the transwells were then placed in the 
LCI system for 72     h to acquire time-lapsed images to measure proliferation of the 
MDSPCs, as described above. As a control, each plate contained wells of   Ercc1      −      /      −       
MDSPCs without transwell membrane inserts. To measure the diff  erentiation 
potential of   Ercc1      −      /      −        MDSPCs  aft  er co-culture, transwell inserts were removed 
aft  er 72     h and the PM media was switched to DM. Aft  er 2  –  3 days, myogenic dif-
ferentiation of the cells was tested by immunostaining for f-MyHC, as described 
above. To quantify diff  erentiation, it was necessary to switch from transwell to 
conditioned media from young WT-MDSPCs to generate suffi   cient cells for 
quantitative immunodetection of myogenic diff  erentiation markers. Young WT-
MDSPCs were cultured for 2 days in 25     cm  2   collagen-coated  fl  asks and then treated 
with diff  erentiation media (DMEM medium supplemented with 2  %   FBS) for 3 
days. Th   e supernatant was collected and used as conditioned media. MDSPCs from 
21-day-old   Ercc1      −      /      −        mice and 2-yr-old WT mice were grown in the presence of 
this conditioned media or unconditioned diff  erentiation media to determine the 
impact on myogenic diff  erentiation.     
  Western blot   .     Th   ree-to-four days aft  er induction of myogenic diff  erentiation, cells 
were lysed in   Laemmli Sample Buff  er   (  Bio-Rad  ), boiled for 5     min, and centrifuged 
at 4,000     r.p.m. for 5     min. Each sample was loaded on a 6  %   SDS-polyacrylamide gel, 
which was run for 2     h by 100     volts and then transferred for 45     min by 20     volts in a 
semi-dry transferring apparatus. Th   e membrane was blocked with 5  %     nonfat dry 
milk   ( Bio-rad )  in  Tris-buff  ered saline Tween-20 for 1     h and then incubated with 
  mouse anti-MyHC (fast) monoclonal antibody   (1:500,   Sigma-Aldrich  ) and   mouse 
anti-  β  -Actin monoclonal antibody   (1:8,000,   Sigma-Aldrich  ), respectively, overnight 
at  4    ° C.  Aft  er washing 3 times with Tris-buff  ered saline Tween-20, the membrane 
was incubated with   rabbit anti-mouse IgG (H       +       L)   (1:5,000,   Pierce  ) for 1     h at room 
temperature. Blots were developed by   ECL solution   (  Pierce  ). Diff  erences in expres-
sion were measured by densitometry using   soft  ware   from   SCION Corporation   
(provided by National Institutes of Health) and reported relative to   β -Actin.   
  Tissue staining      .     Microvascular density was measured by co-staining for dys-
trophin to highlight muscle fi  bres and CD31 to identify endothelial cells present 
within microvessels  35 .  Briefl  y, sections of frozen gastrocnemius muscle were for-
malin fi  xed, blocked with serum, and incubated with primary antibodies including 
  CD31   (1:250;   BD Biosciences  ) and   dystrophin   (1:300,   Abcam  ) for 1     h.   Goat anti-rat 
IgG Alexa Fluor 594   (1:300,   Invitrogen  ) and   donkey anti-rabbit Alexa Fluor 488   
(1:300,   Invitrogen  ) were used to detect CD31 and dystrophin, respectively. DAPI 
was used to identify cell nuclei. For each image, the total number of muscle fi  bres 
and CD31       +        cells were counted, and the ratio of CD31       +        cells to muscle fi  bres was 
reported  35  . To detect   nLacZ   expression, tissue sections were fi  xed in 1  %   glutaral-
dehyde and incubated with 5-bromo-4-chloro-3-indolyl   β -d-galactopyranoside 
(X-gal) solution for 3     h at 37       °  C and counterstained with haematoxylin and  /  or 
eosin. For details on co-localizing CD31 and   nLacZ   staining, see   Supplementary 
Methods .   
  Statistics      .     Statistical analyses were carried out using   SigmaStat   (  Jandel Scientifi  c 
v2.0 )  soft  ware package. Th   e paired Student  ’  s   t  -test or Mann  –  Whitney rank sum test 
was used for direct comparisons between treatment and control groups. For multi-
ple comparisons, the one-way ANOVA or the Kruskal  –  Wallis one-way ANOVA on 
ranks was applied. Pairwise multiple comparisons were performed using the Tuk-
ey  ’  s Test or Dunn  ’  s Method following rank-based ANOVA. All values are expressed 
as the mean       ±       s.d. (or s.e.m. where noted), and   P     <    0.05  was  considered  signifi   c a n t .                         
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